Jeffrey Kahn, director of the Johns Hopkins Berman Institute for Bioethics, discusses the many governance issues connected to gene editing. Plus, he gives a first-hand account of an historic conference in Hong Kong last year in which Dr. He Jiankui shared his research on the birth of the world's first germline genetically engineered babies. What's the future of the governance of this emerging technology?
